Image

The Black Immigrant Project

The Black Immigrant Project

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This stage I trial will examine if the culturally adapted ACES intervention affects cognitive appraisal (self-efficacy and dysfunctional thoughts) and behavioral activation with Black immigrant living with dementia and their care partners over a 1-month and 3-month period.

Description

The proposed study has two major aims. First, the goal is to determine the feasibility of implementing the adapted ACES intervention with Black immigrant families. It uses an explanatory mixed-methods study, including quantitative data collected using a pre-posttest design, and in-depth qualitative interviews with participants following the post-test to understand their experiences with the newly adapted intervention.

Secondly, an extended version of the study will test the potential mechanisms of action in the adapted ACES intervention with Black immigrant caregivers. Specifically, it will examine whether cognitive appraisal and behavioral activation are mechanisms of action that influence the effects of the adapted intervention on care partner outcomes.

Eligibility

Person with dementia:

Inclusion Criteria:

  • Family or self-identified report of dementia/memory loss,
  • Score \<3 on the Six-item Screener.
  • Age 50 or older.
  • Ability to communicate in English.
  • Identify as a Black immigrant.
  • Ability to give verbal assent.

Exclusion Criteria

  • Under age 50.
  • Not a Black immigrant.
  • Cannot communicate in English.
  • Unable to give verbal assent.
    Caregiver

Inclusion criteria:

  • Black immigrant care partner of persons with AD/ADRD.
  • Age 18 or older.
  • Ability to communicate in English.
  • Identify as a first/second-generation Black immigrant.
  • Have had at least 6 months of caregiving (any help or assistance provided to a relative related to dementia/memory loss).

Exclusion Criteria

  • Under age 18.
  • Not first/second generation Black immigrant.
  • Cannot communicate in English.
  • Has less than 6 months of caregiving to a relative with dementia/memory loss.

Study details
    Dementia

NCT07546708

University of Minnesota

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.